• 1. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes

N-Methyl 4-Fluoro-2-(Trifluoromethyl)Aniline Hydrochloride: A Comprehensive Overview

The compound with CAS No. 1215205-13-2, known as N-Methyl 4-fluoro-2-(trifluoromethyl)aniline hydrochloride, is a highly specialized chemical entity that has garnered significant attention in the fields of pharmaceutical research and organic synthesis. This compound is characterized by its unique structural features, which include a trifluoromethyl group, a fluoro substituent, and an N-methyl group attached to the aniline backbone. These substituents confer distinctive electronic and steric properties, making it a valuable building block in the development of novel bioactive molecules.

Recent advancements in medicinal chemistry have highlighted the potential of N-Methyl 4-fluoro-2-(trifluoromethyl)aniline hydrochloride as a precursor for designing inhibitors targeting various therapeutic areas. For instance, studies have demonstrated its utility in the creation of kinase inhibitors, which are critical in the treatment of cancer and inflammatory diseases. The trifluoromethyl group, in particular, has been shown to enhance the compound's lipophilicity and metabolic stability, thereby improving its pharmacokinetic profile.

From a synthetic perspective, the preparation of N-Methyl 4-fluoro-2-(trifluoromethyl)aniline hydrochloride involves a multi-step process that typically begins with the fluorination of an aromatic ring. The introduction of the trifluoromethyl group is often achieved through electrophilic substitution reactions, while the N-methylation step ensures optimal solubility and bioavailability. Researchers have also explored alternative synthetic routes to optimize yield and purity, leveraging modern catalytic techniques and green chemistry principles.

In terms of applications, this compound has found extensive use in drug discovery programs aimed at addressing unmet medical needs. For example, its derivatives have been evaluated for their ability to modulate G-protein coupled receptors (GPCRs), which are key targets in neurodegenerative diseases such as Alzheimer's and Parkinson's. Additionally, N-Methyl 4-fluoro-2-(trifluoromethyl)aniline hydrochloride has been employed in the synthesis of anti-viral agents, particularly those targeting RNA-dependent RNA polymerases involved in viral replication.

Recent studies have also focused on understanding the environmental impact and toxicological profile of N-Methyl 4-fluoro-2-(trifluoromethyl)aniline hydrochloride. Preliminary data suggest that it exhibits low acute toxicity and minimal bioaccumulation potential, making it a safer choice for large-scale production processes. However, further long-term studies are required to fully assess its environmental fate and effects.

Looking ahead, the continued exploration of N-Methyl 4-fluoro-2-(trifluoromethyl)aniline hydrochloride is expected to unlock new opportunities in both academic research and industrial applications. Its versatile structure and favorable pharmacokinetic properties position it as a cornerstone for developing next-generation therapeutics with enhanced efficacy and reduced side effects.

• 393-39-5(2-Amino-5-fluorobenzotrifluoride)
• 14925-10-1(N-Methyl-2-(trifluoromethyl)aniline)
• 139291-82-0(Benzenamine, 4-fluoro-2-(trifluoromethyl)-, hydrochloride)
• 1041583-33-8(N-(4-Fluorobenzyl)-2-(trifluoromethyl)aniline)
• 54672-14-9(N,N-Dimethyl-2-(trifluoromethyl)aniline)
• 1263376-76-6(4-Fluoro-2-trifluoromethylphenylthiourea)
• 827-20-3(5-Fluoro-2-(trifluoromethyl)aniline)
• 946399-69-5(1-4-fluoro-2-(trifluoromethyl)phenylpiperazine)
• 1042510-31-5(N-(3-fluorobenzyl)-2-(trifluoromethyl)aniline)
• 187835-59-2(Benzenamine, 3,6-difluoro-N,N-dimethyl-2,4-bis(trifluoromethyl)-)